The emerging role of endoscopic ultrasound-guided core biopsy for the evaluation of solid pancreatic masses

Keyphrases

• Endoscopic Ultrasound-guided 100%
• Solid Pancreatic Mass 100%
• Ultrasound-guided Core Biopsy 100%
• Resection 66%
• Biopsy Needle 66%
• Chronic Pancreatitis 66%
• Endoscopic Ultrasound-guided Fine-needle Aspiration (EUS-FNA) 66%
• Autoimmune Pancreatitis 66%
• Core Tissue 66%
• Endoscopist 33%
• Disease Diagnosis 33%
• Immunohistochemistry 33%
• Lymphoma 33%
• Surgical Resection 33%
• Histology 33%
• Curative Treatment 33%
• Delayed Diagnosis 33%
• Oncology 33%
• 5-year Survival 33%
• Metastatic Tumor 33%
• Pancreatic Ductal Adenocarcinoma 33%
• Disease Entity 33%
• Early Cancer Detection 33%
• Personalized Medicine 33%
• Accurate Diagnosis 33%
• Fine-needle Aspiration Biopsy 33%
• Diagnostic Accuracy 33%
• Tissue Diagnosis 33%
• Genetic Aberrations 33%
• Neuroendocrine Tumor 33%
• Molecular Biomarkers 33%
• Duodenum 33%
• Focal Lesion 33%
• Lethal Cancer 33%
• Tissue Analysis 33%
• Tissue Architecture 33%
• Pancreatic Head 33%
• Stiffness 33%
• Cytopathology 33%
• Personalized Treatment 33%
• Tissue Core 33%
• Technical Failure 33%
• Tru-cut Biopsy 33%
• 25-gauge 33%
• Pancreatic Mass 33%
• Core Biopsy Needle 33%
• Operation Failure 33%
• Benign Lesions 33%

Medicine and Dentistry

• Malignant Neoplasm 100%
• Biopsy Technique 100%
• Endoscopic Ultrasound 100%
• Endoscopic Ultrasound Guided Fine Needle Biopsy 100%
• Chronic Pancreatitis 100%
• Autoimmune Pancreatitis 100%
• Biological Marker 50%
• Diseases 50%
• Immunohistochemistry 50%
• Metastatic Carcinoma 50%
• Oncology 50%
• Survival Rate 50%
• Pancreas Adenocarcinoma 50%
• Fine-Needle Aspiration 50%
• Personalized Medicine 50%
• Neuroendocrine Tumor 50%
• Diagnostic Accuracy 50%
• Histology 50%
• Duodenum 50%
• Cytopathology 50%
• Early Cancer Diagnosis 50%
• Core Needle Biopsy 50%
• Genetics 50%